top of page
Search

Panakeia PANProfiler Breast receives CE mark

A new AI-based test that can predict the most effective treatment from images of routine cancer samples has been approved for use in the UK and EU, speeding up diagnosis and reducing the need for lab testing. Read more

Comments


panakeia.png
panakeia word logo only.png

Next generation Multi-omics and Biomarker Profiling

About

Panakeia Technologies LTD
Salisbury House, Station Road
Cambridge, England, CB1 2LA
Registration no 11696687

Privacy Policy >

Regulatory Note

Unless otherwise stated all products are intended for Research Use Only, not for use in diagnostic procedures.

Social

  • White Twitter Icon
  • White LinkedIn Icon

© 2024 Panakeia Technologies

bottom of page